Print-ready dossier — use your browser's print dialog to save as PDF.
BTL-699 EXOMIND
Model BTL-699 EXOMIND · BTL INDUSTRIES LIMITED · DI B108699PO3M2MUS00
OBP — Transcranial Magnetic Stimulator · Class II · 21 CFR 882.5805
UDILibrary device dossier · generated 2026-09-16 · sources: FDA GUDID, openFDA (recalls, MAUDE, 510(k)/PMA), FDA Data Dashboard (inspections, compliance actions), 510(k) summary documents.
Recall history (0)
No recalls linked in the loaded window.
Adverse-event reports — MAUDE (0)
Caveat (required reading): MAUDE report counts cannot be used to compute incidence rates or compare device safety. Reporting is incomplete, duplicated, and spikes with publicity; there is no denominator of devices in use. The peer line is a reporting baseline (average device in the same product code), not a risk measure.
Monthly adverse-event reports for this device versus the product-code average.
Month
This device (reports)
Product-code average (reports per device)
2022-04
0
1
2022-06
0
3
2022-07
0
2
2022-08
0
2
2022-09
0
12
2022-10
0
10
2022-12
0
2
2023-01
0
4
2023-02
0
2
2023-03
0
2
2023-04
0
5
2023-05
0
4
2023-06
0
2
2023-07
0
2
2023-08
0
2.67
2023-09
0
4
2023-10
0
2
2023-11
0
1
2023-12
0
1
2024-01
0
2.5
2024-03
0
3
2024-04
0
2
2024-05
0
2
2024-06
0
4
2024-09
0
4
2024-11
0
2
2024-12
0
1
2025-01
0
2
2025-02
0
1.67
2025-03
0
2
2025-04
0
2.5
2025-05
0
2.6
2025-06
0
1.8
2025-07
0
4
2025-08
0
3
2025-09
0
2
2025-11
0
2
2025-12
0
2
2026-01
0
1.5
2026-02
0
2.5
2026-03
0
2.5
2026-04
0
3
2026-05
0
2
2026-06
0
2
This device (reports/month)Average device in OBP (reports/device/month)
Regulatory clearances
None linked in the loaded window.
Manufacturer compliance record — BTL INDUSTRIES LIMITED